SCHEMBL3885808

SCHEMBL3885808

CC1=NN(c2sc3ccccc3[n+]2C)C(=O)/C1=C/C=C/c1ccc(N(C)C)cc1.COS(=O)(=O)[O-]

nearest known ligand 0.58

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 14/20 0.58
MAPK1 P28482 9/20 0.58
KMT2A Q03164 9/20 0.58
L3MBTL1 Q9Y468 6/20 0.58
HTT P42858 6/20 0.58
MEN1 O00255 6/20 0.58
PKM P14618 5/20 0.58
TDP1 Q9NUW8 3/20 0.58
LMNA P02545 2/20 0.58
OPRK1 P41145 2/20 0.58
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
ALDH1A1 P00352 6/20 0.46
POLB P06746 3/20 0.46
NPSR1 Q6W5P4 4/20 0.44
NSD2 O96028 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
INSR P06213 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3885810 1.00 MAPT (0.58) MAPTMAPK1KMT2AL3MBTL1HTT
SCHEMBL3886242 0.90 KMT2A (0.49) MAPTMAPK1KMT2AL3MBTL1HTT
SCHEMBL3886244 0.90 KMT2A (0.49) MAPTMAPK1KMT2AL3MBTL1HTT
SCHEMBL3891294 0.79 SIRT5 (0.43) MAPTKMT2AL3MBTL1HTTMEN1
SCHEMBL3891296 0.79 SIRT5 (0.43) MAPTKMT2AL3MBTL1HTTMEN1
SCHEMBL3893063 0.77 GAA (0.38) MAPTMAPK1KMT2AL3MBTL1HTT
SCHEMBL3893066 0.77 GAA (0.38) MAPTMAPK1KMT2AL3MBTL1HTT
SCHEMBL3888567 0.75 KMT2A (0.50) MAPTKMT2AL3MBTL1HTTMEN1
SCHEMBL3887766 0.75 KMT2A (0.50) MAPTKMT2AL3MBTL1HTTMEN1
SCHEMBL16081336 0.75 MAPT (1.00) MAPTMAPK1KMT2AL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534273-B2 Cationic pyrazolone dyes, method for production thereof and coloring agents for keratin fibers containing said compounds WELLA AG (DE) 2009-05-19 US claimed
US-20080263787-A1 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2008-10-30 US claimed
EP-1771517-A1 CATIONIC PYRAZOLONE DYES METHOD FOR PRODUCTION THEREOF AND COLOURING AGENTS FOR KERATIN FIBRES CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2007-04-11 EP claimed
WO-2006012934-A1 CATIONIC PYRAZOLONE DYES METHOD FOR PRODUCTION THEREOF AND COLOURING AGENTS FOR KERATIN FIBRES CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-02-09 WO claimed
US-7534273-B2 Cationic pyrazolone dyes, method for production thereof and coloring agents for keratin fibers containing said compounds WELLA AG (DE) 2009-05-19 US disclosed
US-20080263787-A1 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds HFC PRESTIGE INTERNATIONAL OPERATIONS SWITZERLAND SÀRL (CH) 2008-10-30 US disclosed
EP-1771517-A1 CATIONIC PYRAZOLONE DYES METHOD FOR PRODUCTION THEREOF AND COLOURING AGENTS FOR KERATIN FIBRES CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2007-04-11 EP disclosed
WO-2006012934-A1 CATIONIC PYRAZOLONE DYES METHOD FOR PRODUCTION THEREOF AND COLOURING AGENTS FOR KERATIN FIBRES CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080263787-A1 Cationic Pyrazolone Dyes, Method for Production Thereof and Coloring Agents for Keratin Fibers Containing Said Compounds KRT18, KLK5, IK MAPT 1821/4885MAPK1 1074/4885KMT2A 3682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.